Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Cash from Financing Activities: 2010-2024

Historic Cash from Financing Activities for Whitehawk Therapeutics (WHWK) over the last 13 years, with Dec 2024 value amounting to $130,000.

  • Whitehawk Therapeutics' Cash from Financing Activities fell 1077.01% to -$850,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $94.5 million, marking a year-over-year increase of 115132.93%. This contributed to the annual value of $130,000 for FY2024, which is 60.12% down from last year.
  • According to the latest figures from FY2024, Whitehawk Therapeutics' Cash from Financing Activities is $130,000, which was down 60.12% from $326,000 recorded in FY2023.
  • In the past 5 years, Whitehawk Therapeutics' Cash from Financing Activities ranged from a high of $141.8 million in FY2021 and a low of $130,000 during FY2024.
  • Moreover, its 3-year median value for Cash from Financing Activities was $326,000 (2023), whereas its average is $24.4 million.
  • Per our database at Business Quant, Whitehawk Therapeutics' Cash from Financing Activities soared by 11,776.38% in 2021 and then plummeted by 99.55% in 2023.
  • Over the past 5 years, Whitehawk Therapeutics' Cash from Financing Activities (Yearly) stood at $1.2 million in 2020, then soared by 11,776.38% to $141.8 million in 2021, then tumbled by 48.79% to $72.6 million in 2022, then tumbled by 99.55% to $326,000 in 2023, then slumped by 60.12% to $130,000 in 2024.